The acquisition of Olink by Thermo Fisher Scientific is a significant event in the proteomics field. Thermo Fisher is a leading provider of analytical instruments and life sciences reagents, and Olink is a leader in protein biomarker discovery and analysis.
This is the second deal in the Next-Generation Proteomics field after SomaLogic announced its intentions to merge with Standard Biotools a few weeks ago.
The acquisition of Olink by Thermo Fisher Scientific has several implications for Olink's products and for competitors in the field, such as Somalogic, Quantum SI and Quanterix: